Modeling Heterogeneity of Triple‐Negative Breast Cancer Uncovers a Novel Combinatorial Treatment Overcoming Primary Drug Resistance-Reference-Cited by-同舟云学术

Modeling Heterogeneity of Triple‐Negative Breast Cancer Uncovers a Novel Combinatorial Treatment Overcoming Primary Drug Resistance

Published:2020-12-16 Issue:3 Volume:8 Page:2003049
ISSN:2198-3844
Container-title:Advanced Science
language:en
Short-container-title:Adv. Sci.

Author:

Lamballe Fabienne¹,Ahmad Fahmida¹,Vinik Yaron²,Castellanet Olivier¹,Daian Fabrice¹,Müller Anna‐Katharina²,Köhler Ulrike A.²,Bailly Anne‐Laure³,Josselin Emmanuelle⁴,Castellano Rémy⁴,Cayrou Christelle³,Charafe‐Jauffret Emmanuelle⁵,Mills Gordon B.⁶,Géli Vincent³,Borg Jean‐Paul³⁷,Lev Sima²,Maina Flavio¹^ORCID

Affiliation:

1. Aix Marseille Univ CNRS Developmental Biology Institute of Marseille (IBDM) Turing Center for Living Systems Parc Scientifique de Luminy Marseille 13009 France

2. Department of Molecular Cell Biology Weizmann Institute of Science Rehovot 76100 Israel

3. Aix Marseille Univ Centre de Recherche en Cancérologie de Marseille (CRCM) Equipes labellisées Ligue ‘Cell polarity, cell signaling and cancer’ and ‘Telomere and Chromatin’ Inserm CNRS Institut Paoli‐Calmettes Marseille 13009 France

4. Aix Marseille Univ Inserm CNRS Institut Paoli‐Calmettes CRCM TrGET Platform Marseille 13009 France

5. Aix Marseille Univ Inserm CNRS Institut Paoli‐Calmettes CRCM Experimental Histo‐Pathology Platform Marseille 13009 France

6. Knight Cancer Institute Portland OR 97201 USA

7. Institut Universitaire de France (IUF) 1 rue Descartes Paris 75231 France

Funder

Institut Universitaire de France

Ministère de l'Enseignement supérieur, de la Recherche et de l'Innovation

Publisher

Wiley

Subject

General Physics and Astronomy,General Engineering,Biochemistry, Genetics and Molecular Biology (miscellaneous),General Materials Science,General Chemical Engineering,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/advs.202003049

Reference66 articles.

1. Mouse models of breast cancer metastasis

2. Mouse models of breast cancer in preclinical research

3. MMTV-PyMT and Derived Met-1 Mouse Mammary Tumor Cells as Models for Studying the Role of the Androgen Receptor in Triple-Negative Breast Cancer Progression

4. Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype

5. Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression Levels and Clinical Significance of WEE1 and mTOR in Triple-Negative Breast Cancer;Indian Journal of Surgery;2024-08-03

2. Prognostic significance of hemoglobin, albumin, lymphocyte, and platelet (HALP) score in breast cancer: a propensity score-matching study;Cancer Cell International;2024-07-02

3. Dynamics of a diffusive model for cancer stem cells with time delay in microRNA-differentiated cancer cell interactions and radiotherapy effects;Scientific Reports;2024-03-04

4. Mucin-1–Targeted Chimeric Antigen Receptor T Cells Are Effective and Safe in Controlling Solid Tumors in Immunocompetent Host;Journal of Immunotherapy;2024-01-25

5. Seize the engine: Emerging cell cycle targets in breast cancer;Clinical and Translational Medicine;2024-01